Agenda item 12.6 and 12.10

On agenda item 12.6: The world remains off track on health-related SDGs, including for Target 3.3, with 1.5 billion people still impacted by NTDs, many lacking appropriate health tools. Sustained investments are needed to close R&D gaps. Partnerships are also key to achieving SDG 3. Along with partners, DNDi has developed and delivered life-saving treatments, yet many pharmaceutical companies are withdrawing from infectious disease R&D, underscoring the need for inclusive, equitable partnerships within and across regions and sectors. With less than five years to 2030, bold and coordinated action is needed.

In relation to agenda 12.10, we ask Member States to ensure that successful technologies do not embed bias and are available for all populations’ benefit – especially technologies that have received public funding. Policies should actively encourage the creation of digital public goods that enable equitable access.